Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma

BACKGROUND: CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL) accounts for 5–10% of DLBCL cases and has poor patient outcomes. However, most studies on CD5+ DLBCL were performed in Japanese patients and only few data are available for Korean population. In this study, we investigated the clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun-Young, Jang, Mi-Ae, Kim, Hee-Jin, Kim, Seok Jin, Kim, Won Seog, Kim, Sun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641511/
https://www.ncbi.nlm.nih.gov/pubmed/29043234
http://dx.doi.org/10.5045/br.2017.52.3.193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641511/
https://www.ncbi.nlm.nih.gov/pubmed/29043234
http://dx.doi.org/10.5045/br.2017.52.3.193

Ejemplares similares